AIMS/HYPOTHESIS: Reactive oxygen species (ROS) contribute to diabetes-induced glomerular injury and endoplasmic reticulum (ER) stress-induced beta cell dysfunction, but the source of ROS has not been fully elucidated. Our aim was to determine whether p47(phox)-dependent activation of NADPH oxidase is responsible for hyperglycaemia-induced glomerular injury in the Akita mouse, a model of type 1 diabetes mellitus resulting from ER stress-induced beta cell dysfunction. METHODS: We examined the effect of deleting p47 (phox) (also known as Ncf1), the gene for the NADPH oxidase subunit, on diabetic nephropathy in the Akita mouse (Ins2 (WT/C96Y)) by studying four groups of mice: (1) non-diabetic mice (Ins2 (WT/WT)/p47 (phox+/+)); (2) non-diabetic p47 (phox)-null mice (Ins2 (WT/WT)/p47 (phox-/-)); (3) diabetic mice: (Ins2 (WT/C96Y)/p47 (phox+/+)); and (4) diabetic p47 (phox)-null mice (Ins2 (WT/C96Y)/p47 (phox-/-)). We measured the urinary albumin excretion rate, oxidative stress, mesangial matrix expansion, and plasma and pancreatic insulin concentrations in 16-week-old mice; we also measured glucose tolerance and insulin sensitivity, islet and glomerular NADPH oxidase activity and subunit expression, and pro-fibrotic gene expression in 8-week-old mice. In addition, we measured NADPH oxidase activity, subunit expression and pro-fibrotic gene expression in high glucose-treated murine mesangial cells. RESULTS: Deletion of p47 (phox) reduced kidney hypertrophy, oxidative stress and mesangial matrix expansion, and also reduced hyperglycaemia by increasing pancreatic and circulating insulin concentrations. p47 (phox-/-) mice exhibited improved glucose tolerance, but modestly decreased insulin sensitivity. Deletion of p47 (phox) attenuated high glucose-induced activation of NADPH oxidase and pro-fibrotic gene expression in glomeruli and mesangial cells. CONCLUSIONS/ INTERPRETATION: Deletion of p47 (phox) attenuates diabetes-induced glomerular injury and beta cell dysfunction in the Akita mouse.
AIMS/HYPOTHESIS: Reactive oxygen species (ROS) contribute to diabetes-induced glomerular injury and endoplasmic reticulum (ER) stress-induced beta cell dysfunction, but the source of ROS has not been fully elucidated. Our aim was to determine whether p47(phox)-dependent activation of NADPH oxidase is responsible for hyperglycaemia-induced glomerular injury in the Akita mouse, a model of type 1 diabetes mellitus resulting from ER stress-induced beta cell dysfunction. METHODS: We examined the effect of deleting p47 (phox) (also known as Ncf1), the gene for the NADPH oxidase subunit, on diabetic nephropathy in the Akita mouse (Ins2 (WT/C96Y)) by studying four groups of mice: (1) non-diabeticmice (Ins2 (WT/WT)/p47 (phox+/+)); (2) non-diabeticp47 (phox)-null mice (Ins2 (WT/WT)/p47 (phox-/-)); (3) diabeticmice: (Ins2 (WT/C96Y)/p47 (phox+/+)); and (4) diabeticp47 (phox)-null mice (Ins2 (WT/C96Y)/p47 (phox-/-)). We measured the urinary albumin excretion rate, oxidative stress, mesangial matrix expansion, and plasma and pancreatic insulin concentrations in 16-week-old mice; we also measured glucose tolerance and insulin sensitivity, islet and glomerular NADPH oxidase activity and subunit expression, and pro-fibrotic gene expression in 8-week-old mice. In addition, we measured NADPH oxidase activity, subunit expression and pro-fibrotic gene expression in high glucose-treated murine mesangial cells. RESULTS: Deletion of p47 (phox) reduced kidney hypertrophy, oxidative stress and mesangial matrix expansion, and also reduced hyperglycaemia by increasing pancreatic and circulating insulin concentrations. p47 (phox-/-) mice exhibited improved glucose tolerance, but modestly decreased insulin sensitivity. Deletion of p47 (phox) attenuated high glucose-induced activation of NADPH oxidase and pro-fibrotic gene expression in glomeruli and mesangial cells. CONCLUSIONS/ INTERPRETATION: Deletion of p47 (phox) attenuates diabetes-induced glomerular injury and beta cell dysfunction in the Akita mouse.
Authors: Yuzuru Ohshiro; Ronald C Ma; Yutaka Yasuda; Junko Hiraoka-Yamamoto; Allen C Clermont; Keiji Isshiki; Kunimasa Yagi; Emi Arikawa; Timothy S Kern; George L King Journal: Diabetes Date: 2006-11 Impact factor: 9.461
Authors: K Horie; T Miyata; K Maeda; S Miyata; S Sugiyama; H Sakai; C van Ypersole de Strihou; V M Monnier; J L Witztum; K Kurokawa Journal: J Clin Invest Date: 1997-12-15 Impact factor: 14.808
Authors: Yufeng Huang; Wayne A Border; Ling Yu; Jiandong Zhang; Daniel A Lawrence; Nancy A Noble Journal: J Am Soc Nephrol Date: 2008-01-23 Impact factor: 10.121
Authors: T Etoh; T Inoguchi; M Kakimoto; N Sonoda; K Kobayashi; J Kuroda; H Sumimoto; H Nawata Journal: Diabetologia Date: 2003-09-12 Impact factor: 10.122
Authors: Balu K Chacko; Colin Reily; Anup Srivastava; Michelle S Johnson; Yaozu Ye; Elena Ulasova; Anupam Agarwal; Kurt R Zinn; Michael P Murphy; Balaraman Kalyanaraman; Victor Darley-Usmar Journal: Biochem J Date: 2010-11-15 Impact factor: 3.857
Authors: Chelsey Pye; Nehal M Elsherbiny; Ahmed S Ibrahim; Gregory I Liou; Ahmed Chadli; Mohamed Al-Shabrawey; Ahmed A Elmarakby Journal: Pharmacol Res Date: 2014-05-17 Impact factor: 7.658
Authors: Jianli Bi; Stephen A Contag; Kai Chen; Yixin Su; Jorge P Figueroa; Mark C Chappell; James C Rose Journal: Am J Physiol Renal Physiol Date: 2014-09-10
Authors: Celio X C Santos; Adam A Nabeebaccus; Ajay M Shah; Livia L Camargo; Sidney V Filho; Lucia R Lopes Journal: Antioxid Redox Signal Date: 2013-05-01 Impact factor: 8.401
Authors: K Koulajian; T Desai; G C Liu; A Ivovic; J N Patterson; C Tang; J El-Benna; J W Joseph; J W Scholey; A Giacca Journal: Diabetologia Date: 2013-02-21 Impact factor: 10.122
Authors: Decui Shao; Jia Liu; Jun Ni; Zhen Wang; Yang Shen; Li Zhou; Yu Huang; Jun Wang; Hong Xue; Wei Zhang; Limin Lu Journal: PLoS One Date: 2013-02-14 Impact factor: 3.240